Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Discontinued products
Discontinued Product name |
PIP Code |
Date of discontinuation |
|---|---|---|
| AMOXIL PAED 100MG/ML 1X20ML | 10835 | Mid 2020 |
| AUGMENTIN INJ VIAL 1.2G 1X10ML | 2342616 | Nov 2021 |
| AUGMENTIN VIAL 500/100MG 10x25ML_GB | 171330 | Nov 2021 |
| CERVARIX VACCINE PFS 0.5ML 500ML | 3308301 | March 2021 |
| CELSENTRI 25MG TABLETS | 4052999 | Aug 2021 |
| CELSENTRI 75MG TABLETS | 4052981 | Aug 2021 |
| CUTIVATE CREAM 0.05% 30G | 3470101 | Nov 2020 |
| CUTIVATE CREAM 0.05% 15G | 2075216 | Nov 2020 |
| CUTIVATE OINTMENT 0.005% 15G | 2247146 | Nov 2020 |
| HALERAID 120 INHALATION DEVICE 1 | 211-8115 | Mid 2020 |
| HALERAID 200 INHALATION DEVICE 1 | 162-743 | Mid 2020 |
| RABIPUR PFS X 1 | 4044921 | March 2021 |
| TELZIR ORAL SUSP 50MG/ML x 225ML | 3101193 | July 2021 |
| TIMENTIN VIALS 3.2G x 4 | 4192 | Nov 2020 |
| VENTOLIN NEBULE 2.5MG 20x2.5ML | 204982 | Jan 2022 |
| VENTOLIN NEBULE 5MG 20X2.5ML | 188714 | Dec 2021 |
| FLIXONASE NASULES 400MCG/400MCL 1X28 | 2618114 | Oct 2023 |
| SEROXAT SUSP 150ml | 2408805 | Aug 2022 |
| FLIXOTIDE NEBULE 0.5MG/2ML 1X10 | 2589588 | Sep 2022 |
| FLIXOTIDE NEBULE 2MG/2ML 1X10 | 2589570 | May 2023 |
| TIVICAY TABLET 10MG 1X30_GB | 4042529 | Feb 2023 |
| TIVICAY TABLET 25MG 1X30_GB | 4042511 | Mar 2023 |
| TRIZIVIR TABLET 300/150/300MG 5X12 | 2734549 | May 2023 |
| TELZIR TAB 700MG 1X60_GB | 3078557 | Oct 2022 |
| ZOVIRAX TABLETS 800MG X 35 | 482265 | May 2023 |
| INTEGRILIN INF 0.75MG/ML 100ML UK GSK | 2640761 | Oct 2023 |
| INTEGRILIN INJ 2MG/ML10ML UK GSK | 2640688 | Oct 2023 |
| INTEGRILIN INF 0.75MG/ML100ML_XI/IE GSK | 5203252 | Oct 2023 |
| INTEGRILIN INJVL 2MG/ML 1X10ML XI/IE/NL | 5203245 | Oct 2023 |
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.
